[1]
2018. DESIGN AND IN VIVO EVALUATION OF CONTROLLED RELEASE GLICLAZIDE TRILAYER MATRIX TABLETS IN THE MANAGEMENT OF DIABETES MELLITUS. International Journal of Pharmaceutical Sciences and Drug Research. 10, 5 (Sep. 2018), 410–417. DOI:https://doi.org/10.25004/IJPSDR.2018.100508.